Aurobindo Pharma Hiring for Formulation AR&D, FR&D, E&L Roles

Aurobindo Pharma, a global leader committed to delivering healthier lives, invites skilled professionals to join their team. The organization is actively hiring for Formulation Analytical Research & Development (AR&D), Formulation Research & Development (FR&D), and Extractables and Leachables (E&L) roles at in Hyderabad. If you have a strong background in pharmaceutical sciences and are seeking an opportunity to advance your career, this is your chance!

Job Opportunities at Aurobindo Pharma

1. Formulation Analytical Research & Development (AR&D)

Role Highlights:

• Development of analytical methods and routine analysis.
• Hands-on expertise with LCMS techniques.
• Responsible for analytical method validation and stability studies.

Qualification & Experience:

• Qualification: M. Pharmacy or MSc in Pharmaceutical Sciences.
• Experience: 3–8 years in analytical research and method development.

2. Formulation Research & Development (FR&D)

Role Highlights:

• Formulation development of Oral Solid Dosages (OSD) for regulatory markets.
• Expertise in developing Immediate Release (IR), Extended Release (ER), and Delayed Release (DR) formulations.
• Exposure to pellet formulation processes is desirable.

Qualification & Experience:

• Qualification: M. Pharmacy in Pharmaceutics.
• Experience: 3–5 years in formulation research and development.

3. Extractables and Leachables (E&L)

Role Highlights:

• Perform studies on extractables and leachables for various dosage forms.
• Design and implement methods to evaluate E&L profiles in drug products.

Qualification & Experience:

• Qualification: M. Pharmacy or MSc.
• Experience: 4–10 years of hands-on experience in E&L assessments.

Walk-In Drive Details

Date: Sunday, 22nd December 2024
Time: 9:00 AM to 2:00 PM
Venue: Aurobindo Pharma Ltd, APL Research Centre-1, Sy. No. 313, Qutubullapur, Bachupally, Hyderabad, Telangana-500090.

Contact:
Interested candidates can send their updated resumes to Hrrc1@aurobindo.com.